Abstract
Uncontrolled severe asthma (AGNC) is defined as the disease that persists in poorly controlled despite receiving treatment with a combination of a high-dose inhaled corticosteroid (CI) and a long-acting beta-2-adrenergic agonist (LABA, of English long acting beta 2 agonist) during the last year, or with oral corticosteroids (CO) for at least six months of the same period
Keywords
Dupilumab; Asthma; Biological
Bibliographic citation
Programa d'Harmonització Farmacoterapèutica. Dupilumab per al tractament de l’asma greu no controlada. Barcelona: Servei Català de la Salut; 2022.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/7366This item appears in following collections
The following license files are associated with this item: